Perkins Coie Trust Co Lowers Stock Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

Perkins Coie Trust Co cut its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 5.4% during the fourth quarter, Holdings Channel reports. The firm owned 23,137 shares of the financial services provider’s stock after selling 1,309 shares during the quarter. Perkins Coie Trust Co’s holdings in iShares Biotechnology ETF were worth $3,059,000 at the end of the most recent quarter.

Other hedge funds have also made changes to their positions in the company. PVG Asset Management Corp acquired a new stake in shares of iShares Biotechnology ETF in the second quarter valued at $415,000. Huntington National Bank increased its holdings in iShares Biotechnology ETF by 17.9% during the 3rd quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after purchasing an additional 160 shares during the period. National Bank of Canada FI raised its position in iShares Biotechnology ETF by 5.9% in the 3rd quarter. National Bank of Canada FI now owns 4,124 shares of the financial services provider’s stock valued at $600,000 after purchasing an additional 229 shares in the last quarter. First Financial Bank Trust Division purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $204,000. Finally, Thrive Wealth Management LLC purchased a new position in shares of iShares Biotechnology ETF in the 3rd quarter valued at about $445,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

IBB stock opened at $132.65 on Friday. The company’s 50 day moving average price is $136.62 and its 200 day moving average price is $141.81. iShares Biotechnology ETF has a fifty-two week low of $123.60 and a fifty-two week high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a dividend, which was paid on Friday, December 20th. Shareholders of record on Tuesday, December 17th were given a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.